Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results

Bruce D. Cheson; Nancy L. Bartlett; Betsy Knopf; Hun J. Lee; Ranjana H. Advani; Beth Christian; Catherine S. Diefenbach; Tatyana A. Feldman; Stephen M. Ansell

doi:10.1182/bloodadvances.2025016470

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results

Bruce D. Cheson
, Nancy L. Bartlett
, Betsy Knopf
, Hun J. Lee
, Ranjana H. Advani
, Beth Christian
, Catherine S. Diefenbach
, Tatyana A. Feldman
, Stephen M. Ansell

School of Medicine

Hackensack Meridian School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3750-3753
Number of pages	4
Journal	Blood Advances
Volume	9
Issue number	15
DOIs	https://doi.org/10.1182/bloodadvances.2025016470
State	Published - Aug 12 2025

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2025016470

Cite this

@article{18ff6587f73246a1a16518834481e624,

title = "Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results",

author = "Cheson, \{Bruce D.\} and Bartlett, \{Nancy L.\} and Betsy Knopf and Lee, \{Hun J.\} and Advani, \{Ranjana H.\} and Beth Christian and Diefenbach, \{Catherine S.\} and Feldman, \{Tatyana A.\} and Ansell, \{Stephen M.\}",

year = "2025",

month = aug,

day = "12",

doi = "10.1182/bloodadvances.2025016470",

language = "English",

volume = "9",

pages = "3750--3753",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "15",

}

TY - JOUR

T1 - Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma

T2 - long-term results

AU - Cheson, Bruce D.

AU - Bartlett, Nancy L.

AU - Knopf, Betsy

AU - Lee, Hun J.

AU - Advani, Ranjana H.

AU - Christian, Beth

AU - Diefenbach, Catherine S.

AU - Feldman, Tatyana A.

AU - Ansell, Stephen M.

PY - 2025/8/12

Y1 - 2025/8/12

UR - https://www.scopus.com/pages/publications/105012119463

U2 - 10.1182/bloodadvances.2025016470

DO - 10.1182/bloodadvances.2025016470

M3 - Letter

C2 - 40311072

SN - 2473-9529

VL - 9

SP - 3750

EP - 3753

JO - Blood Advances

JF - Blood Advances

IS - 15

ER -

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this